On Monday, September 14, 2020, the CSP Preparatory Course will cover material based on the new content outline for the CSP examination, which was updated on April 1, 2020. The CSP Examination for the October-November 2020 time period will remain the same as the previous examinations.
The National Association of Specialty Pharmacy (NASP) has teamed up with ProCE to bring you the Center for Specialty Pharmacy Education (CSPE), the official continuing education website for NASP. Most CSPE activities cover the clinical therapeutics of various disease states in which specialty pharmacy products and services are provided. However, CSPE also covers legal, regulatory, and operational topics relevant to specialty pharmacy practice.
Specialty pharmacy is the fastest growing segment of pharmacy practice today and will continue to be for the foreseeable future. Specialty pharmacy impacts only a small percentage of the population; however, the diseases and drug therapies are very complex and require a higher level of knowledge compared to more traditional diseases and drug therapies. The Certified Specialty Pharmacist Credential is designed to help you validate your professional expertise, elevate the status of the specialty pharmacy profession, differentiate yourself in a competitive job market, provide understanding for when handling limited or exclusively distributed drugs, position yourself to better serve payer requirements, and protect the public by improving health outcomes and reducing medication errors.
The CSP Exam Preparatory Course will cover topics related to intake, clinical management, fulfillment, and outcomes that might be expected on the exam. Join expert faculty as key aspects of specialty pharmacy and the specialty pharmacist’s role are discussed. Key topics include the fundamentals of the patient intake process, as well as fulfillment workflows and commonly used tools to monitor quality of life, persistence, and adherence. In discussing the disease state, specific sections will cover specialty drug classes, indications, dosing, common side effects and drug interactions, and more. In addition, there will be an opportunity to pose questions to a panel of pharmacists who have taken and passed the exam.
|10:00 AM - 11:00 AM||Oncology||Emily C. Eastman, PharmD, MBA, CSP|
|11:00 AM - 12:00 PM||Hematology||Marcy Snell, PharmD, CSP|
|12:00 PM – 12:30 PM||Break / Audience Q&A|
|12:30 PM - 1:00 PM||CF / Solid Organ Transplant||TBA|
|1:00 PM – 2:00 PM||HepC / HIV||Kristin W. Whelchel, PharmD|
|2:00 PM – 3:00 PM||Multiple Sclerosis & Neurological Conditions||Selina M. Mullins, PharmD, MBA|
|3:00 PM – 3:15 PM||Break / Audience Q&A|
|3:15 PM – 3:45 PM||Pulmonary Arterial Hypertension & Cardiology||Brenda L Gray, PharmD, CNSC, BCNSP, VA-BC, PRS, VCAA(c)|
|3:45 PM – 4:45 PM||Operations||Mel J. Nelson, PharmD, CSP |
Rushabh M. Shah, PharmD, MBA, AAHIVP, CSP
|4:45 PM – 5:45 PM||Inflammatory Diseases||TBA|
|5:45 PM – 6:00 PM||Audience Q&A|
Note: Subject to change